Literature DB >> 6264461

Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA.

A Srinivasan, E P Reddy, S A Aaronson.   

Abstract

The integrated proviral genome of Abelson murine leukemia virus (A-MuLV) was cloned in lambda gtWES . lambda B bacteriophage after EcoRI endonuclease digestion and enrichment of proviral sequences by sequential RPC-5 column chromatography and agarose gel electrophoresis. Recombinant DNA clones containing a 7.8-kilobase-pair EcoRI insert were shown to have the entire integrated A-MuLV genome with both 5' and 3' ends flanked by mink cellular DNA sequences. This DNA fragment was shown to induce focus transformation upon transfection of NIH/3T3 mouse cells. Moreover, focus-forming virus could be rescued from transformed nonproducer cells upon superinfection with a type C helper virus. A polyprotein of molecular weight 120,000 (p120) containing murine leukemia virus gag gene determinants was invariably deteced by immunoprecipitation analysis of individual transformants induced by the 7.8-kilobase-pair DNA. Molecularly cloned integrated A-MuLV in its infectious form should be of use in elucidating the mechanisms involved in transformation by this virus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264461      PMCID: PMC319286          DOI: 10.1073/pnas.78.4.2077

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  In vitro transformation of lymphoid cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.

Authors:  J M Taylor; R Illmensee; J Summers
Journal:  Biochim Biophys Acta       Date:  1976-09-06

4.  Cloning specific segments of the mammalian genome: bacteriophage lambda containing mouse globin and surrounding gene sequences.

Authors:  S M Tilghman; D C Tiemeier; F Polsky; M H Edgell; J G Seidman; A Leder; L W Enquist; B Norman; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

5.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

6.  Nonproducer clones of murine sarcoma virus transformed BALB-3T3 cells.

Authors:  S A Aaronson; S P Rowe
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  A simple method for DNA restriction site mapping.

Authors:  H O Smith; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

9.  Purification and cloning of a mouse ribosomal gene fragment in coliphage lambda.

Authors:  D C Tiemeier; S M Tilghman; P Leder
Journal:  Gene       Date:  1977       Impact factor: 3.688

10.  In vitro packaging of a lambda Dam vector containing EcoRI DNA fragments of Escherichia coli and phage P1.

Authors:  N Sternberg; D Tiemeier; L Enquist
Journal:  Gene       Date:  1977-05       Impact factor: 3.688

View more
  43 in total

1.  Generation of hybrid human immunodeficiency virus utilizing the cotransfection method and analysis of cellular tropism.

Authors:  A Velpandi; T Nagashunmugam; S Murthy; M Cartas; C Monken; A Srinivasan
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases.

Authors:  G D Kruh; R Perego; T Miki; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells.

Authors:  A Srinivasan; C S Goldsmith; D York; R Anand; P Luciw; G Schochetman; E Palmer; C Bohan
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  In vitro-derived leukemic erythroid cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin.

Authors:  S P Klinken; N A Nicola; G R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Gene localization on sorted chromosomes: definitive evidence on the relative positioning of genes participating in the mouse plasmacytoma-associated typical translocation.

Authors:  Z Wirschubsky; S Ingvarsson; A Carstenssen; F Wiener; G Klein; J Sümegi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Superinfection of a chimpanzee with a second strain of human immunodeficiency virus.

Authors:  P N Fultz; A Srinivasan; C R Greene; D Butler; R B Swenson; H M McClure
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias.

Authors:  T J Gonda; S Cory; P Sobieszczuk; D Holtzman; J M Adams
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

8.  Detection and cloning of human DNA sequences related to the mouse mammary tumor virus genome.

Authors:  R Callahan; W Drohan; S Tronick; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Abelson murine leukemia virus: structural requirements for transforming gene function.

Authors:  A Srinivasan; C Y Dunn; Y Yuasa; S G Devare; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Human recipient cell for oncogene transfection studies.

Authors:  M A Tainsky; F L Shamanski; D Blair; G Vande Woude
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.